These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 22154938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition.
    Farady CJ, Egea PF, Schneider EL, Darragh MR, Craik CS.
    J Mol Biol; 2008 Jul 04; 380(2):351-60. PubMed ID: 18514224
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The trimeric serine protease HtrA1 forms a cage-like inhibition complex with an anti-HtrA1 antibody.
    Ciferri C, Lipari MT, Liang WC, Estevez A, Hang J, Stawicki S, Wu Y, Moran P, Elliott M, Eigenbrot C, Katschke KJ, van Lookeren Campagne M, Kirchhofer D.
    Biochem J; 2015 Dec 01; 472(2):169-81. PubMed ID: 26385991
    [Abstract] [Full Text] [Related]

  • 5. Matriptase-3 is a novel phylogenetically preserved membrane-anchored serine protease with broad serpin reactivity.
    Szabo R, Netzel-Arnett S, Hobson JP, Antalis TM, Bugge TH.
    Biochem J; 2005 Aug 15; 390(Pt 1):231-42. PubMed ID: 15853774
    [Abstract] [Full Text] [Related]

  • 6. Catalytic domain structures of MT-SP1/matriptase, a matrix-degrading transmembrane serine proteinase.
    Friedrich R, Fuentes-Prior P, Ong E, Coombs G, Hunter M, Oehler R, Pierson D, Gonzalez R, Huber R, Bode W, Madison EL.
    J Biol Chem; 2002 Jan 18; 277(3):2160-8. PubMed ID: 11696548
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neutralization of Burkholderia pseudomallei protease by Fabs generated through phage display.
    Nathan S, Rader C, Barbas CF.
    Biosci Biotechnol Biochem; 2005 Dec 18; 69(12):2302-11. PubMed ID: 16377887
    [Abstract] [Full Text] [Related]

  • 9. Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors.
    Tamberg T, Hong Z, De Schepper D, Skovbjerg S, Dupont DM, Vitved L, Schar CR, Skjoedt K, Vogel LK, Jensen JK.
    J Biol Chem; 2019 Jan 04; 294(1):314-326. PubMed ID: 30409910
    [Abstract] [Full Text] [Related]

  • 10. High-affinity cyclic peptide matriptase inhibitors.
    Quimbar P, Malik U, Sommerhoff CP, Kaas Q, Chan LY, Huang YH, Grundhuber M, Dunse K, Craik DJ, Anderson MA, Daly NL.
    J Biol Chem; 2013 May 10; 288(19):13885-96. PubMed ID: 23548907
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors.
    Yamasaki Y, Satomi S, Murai N, Tsuzuki S, Fushiki T.
    J Nutr Sci Vitaminol (Tokyo); 2003 Feb 10; 49(1):27-32. PubMed ID: 12882393
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins.
    Velasco G, Cal S, Quesada V, Sánchez LM, López-Otín C.
    J Biol Chem; 2002 Oct 04; 277(40):37637-46. PubMed ID: 12149247
    [Abstract] [Full Text] [Related]

  • 15. Mouse DESC1 is located within a cluster of seven DESC1-like genes and encodes a type II transmembrane serine protease that forms serpin inhibitory complexes.
    Hobson JP, Netzel-Arnett S, Szabo R, Réhault SM, Church FC, Strickland DK, Lawrence DA, Antalis TM, Bugge TH.
    J Biol Chem; 2004 Nov 05; 279(45):46981-94. PubMed ID: 15328353
    [Abstract] [Full Text] [Related]

  • 16. Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II.
    Gray K, Elghadban S, Thongyoo P, Owen KA, Szabo R, Bugge TH, Tate EW, Leatherbarrow RJ, Ellis V.
    Thromb Haemost; 2014 Aug 05; 112(2):402-11. PubMed ID: 24696092
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Engineering of a macromolecular scaffold to develop specific protease inhibitors.
    Stoop AA, Craik CS.
    Nat Biotechnol; 2003 Sep 05; 21(9):1063-8. PubMed ID: 12923547
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.